Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Shorter dialysis times are associated with higher mortality among incident hemodialysis patients.

Brunelli SM, Chertow GM, Ankers ED, Lowrie EG, Thadhani R.

Kidney Int. 2010 Apr;77(7):630-6. doi: 10.1038/ki.2009.523. Epub 2010 Jan 20.

2.

Illustrating use of a clinical data system: the NMC-FMC system.

Lowrie EG.

Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S41-8. doi: 10.2215/CJN.02680409. Review. No abstract available.

3.

Does a statistical method suggest a new pathobiology for hemodialysis patients?

Lowrie EG.

J Am Soc Nephrol. 2009 Sep;20(9):1867-9. doi: 10.1681/ASN.2009060649. Epub 2009 Aug 27. No abstract available.

4.

Prescribing and monitoring hemodialysis dose.

Lowrie EG.

Kidney Int. 2008 Aug;74(3):262-4. doi: 10.1038/ki.2008.224.

5.

The kinetic behaviors of urea and other marker molecules during hemodialysis.

Lowrie EG.

Am J Kidney Dis. 2007 Aug;50(2):181-3. No abstract available.

PMID:
17660018
6.

The epidemiology of systolic blood pressure and death risk in hemodialysis patients.

Li Z, Lacson E Jr, Lowrie EG, Ofsthun NJ, Kuhlmann MK, Lazarus JM, Levin NW.

Am J Kidney Dis. 2006 Oct;48(4):606-15.

PMID:
16997057
7.

The tortoise and hare on hemodialysis: does slow and steady win the race?

Chertow GM, Kurella M, Lowrie EG.

Kidney Int. 2006 Jul;70(1):24-5. Epub 2006 Jun 7. Review.

8.

Evaluating a new method to judge dialysis treatment using online measurements of ionic clearance.

Lowrie EG, Li Z, Ofsthun NJ, Lazarus JM.

Kidney Int. 2006 Jul;70(1):211-7. Epub 2006 May 24.

9.

To reuse or not to reuse: a tale of 2 studies.

Lowrie EG, Ofsthun NJ.

Am J Kidney Dis. 2006 Feb;47(2):372; author reply 372-3. No abstract available.

PMID:
16431272
10.

The online measurement of hemodialysis dose (Kt): clinical outcome as a function of body surface area.

Lowrie EG, Li Z, Ofsthun N, Lazarus JM.

Kidney Int. 2005 Sep;68(3):1344-54.

11.

Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial.

Reddan DN, Szczech LA, Hasselblad V, Lowrie EG, Lindsay RM, Himmelfarb J, Toto RD, Stivelman J, Winchester JF, Zillman LA, Califf RM, Owen WF Jr.

J Am Soc Nephrol. 2005 Jul;16(7):2162-9. Epub 2005 Jun 1.

12.

Measurement of dialyzer clearance, dialysis time, and body size: death risk relationships among patients.

Lowrie EG, Li Z, Ofsthun N, Lazarus JM.

Kidney Int. 2004 Nov;66(5):2077-84.

13.

Dialysis dose and gender: a different hypothesis.

Lowrie EG, Ofsthun N, Li Z.

Kidney Int. 2004 Sep;66(3):1291-2; author reply 1292. No abstract available.

14.

Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis.

Pillon L, Piccoli A, Lowrie EG, Lazarus JM, Chertow GM.

Kidney Int. 2004 Sep;66(3):1266-71.

15.

Reprocessing dialysers for multiple uses: recent analysis of death risks for patients.

Lowrie EG, Li Z, Ofsthun N, Lazarus JM.

Nephrol Dial Transplant. 2004 Nov;19(11):2823-30. Epub 2004 Aug 17.

PMID:
15316099
16.

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM.

J Am Soc Nephrol. 2004 Aug;15(8):2208-18.

17.

Urea space and body water.

Lowrie EG.

Kidney Int. 2004 Aug;66(2):868. No abstract available.

18.

Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients.

Szczech LA, Reddan DN, Klassen PS, Coladonato J, Chua B, Lowrie EG, Lazarus JM, Owen WF Jr.

Nephrol Dial Transplant. 2003 Aug;18(8):1585-91.

PMID:
12897099
19.

Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients.

Lowrie EG, Curtin RB, LePain N, Schatell D.

Am J Kidney Dis. 2003 Jun;41(6):1286-92.

PMID:
12776282
20.

White blood cells as a novel mortality predictor in haemodialysis patients.

Reddan DN, Klassen PS, Szczech LA, Coladonato JA, O'Shea S, Owen WF Jr, Lowrie EG.

Nephrol Dial Transplant. 2003 Jun;18(6):1167-73.

PMID:
12748351
21.

Toward a continuous quality improvement paradigm for hemodialysis providers with preliminary suggestions for clinical practice monitoring and measurement.

Lowrie EG, Teng M, Lew NL, Lacson EJ, Lazarus JM, Owen WF.

Hemodial Int. 2003 Jan 1;7(1):28-51. doi: 10.1046/j.1492-7535.2003.00003.x.

PMID:
19379340
22.

Body size, dialysis dose and death risk relationships among hemodialysis patients.

Lowrie EG, Li Z, Ofsthun N, Lazarus JM.

Kidney Int. 2002 Nov;62(5):1891-7.

23.

National profile of practice patterns for hemodialysis vascular access in the United States.

Reddan D, Klassen P, Frankenfield DL, Szczech L, Schwab S, Coladonato J, Rocco M, Lowrie EG, Owen WF Jr; National ESRD CPM Work Group.

J Am Soc Nephrol. 2002 Aug;13(8):2117-24.

24.

Chronic inflammation and clinical outcome in adult hemodialysis patients.

Lowrie EG.

Kidney Int Suppl. 2002 May;(80):94-8. Review. No abstract available.

PMID:
11982821
25.

Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis.

Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, Lazarus JM, Owen WF Jr.

JAMA. 2002 Mar 27;287(12):1548-55.

PMID:
11911757
26.

Association between prevalent care process measures and facility-specific mortality rates.

Lowrie EG, Teng M, Lacson E, Lew N, Lazarus JM, Owen WF.

Kidney Int. 2001 Nov;60(5):1917-29.

27.

Changing hemodialysis thresholds for optimal survival.

Szczech LA, Lowrie EG, Li Z, Lew NL, Lazarus JM, Owen WF Jr.

Kidney Int. 2001 Feb;59(2):738-45.

28.

Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients.

Chertow GM, Ackert K, Lew NL, Lazarus JM, Lowrie EG.

Kidney Int. 2000 Dec;58(6):2512-7.

29.

The normalized treatment ratio (Kt/V) is not the best dialysis dose parameter.

Lowrie EG.

Blood Purif. 2000;18(4):286-94. Review. No abstract available.

PMID:
10965069
30.

Dose of hemodialysis and survival: can we trust important outcomes to a flawed measure?

Szczech LA, Reddan DN, Lowrie EG, Owen WF Jr.

Int J Artif Organs. 2000 Jul;23(7):411-4. No abstract available.

PMID:
10941632
31.

What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?

Bergström J, Lindholm B, Lacson E Jr, Owen W Jr, Lowrie EG, Glassock RJ, Ikizler TA, Wessels FJ, Moldawer LL, Wanner C, Zimmermann J.

Semin Dial. 2000 May-Jun;13(3):163-75. No abstract available.

PMID:
10833777
32.

Comparing the urea reduction ratio and the urea product as outcome-based measures of hemodialysis dose.

Li Z, Lew NL, Lazarus JM, Lowrie EG.

Am J Kidney Dis. 2000 Apr;35(4):598-605.

PMID:
10739778
33.

Vintage, nutritional status, and survival in hemodialysis patients.

Chertow GM, Johansen KL, Lew N, Lazarus JM, Lowrie EG.

Kidney Int. 2000 Mar;57(3):1176-81.

34.

Quality-of-life evaluation using Short Form 36: comparison in hemodialysis and peritoneal dialysis patients.

Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang H, Lazarus JM.

Am J Kidney Dis. 2000 Feb;35(2):293-300.

PMID:
10676729
35.

Exploring the reverse J-shaped curve between urea reduction ratio and mortality.

Chertow GM, Owen WF, Lazarus JM, Lew NL, Lowrie EG.

Kidney Int. 1999 Nov;56(5):1872-8.

36.

Body weight-for-height relationships predict mortality in maintenance hemodialysis patients.

Kopple JD, Zhu X, Lew NL, Lowrie EG.

Kidney Int. 1999 Sep;56(3):1136-48.

37.

The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose.

Lowrie EG, Chertow GM, Lew NL, Lazarus JM, Owen WF.

Kidney Int. 1999 Aug;56(2):729-37.

38.

Self-reported functional status: an important predictor of health outcomes among end-stage renal disease patients.

Curtin RB, Lowrie EG, DeOreo PB.

Adv Ren Replace Ther. 1999 Apr;6(2):133-40. Review.

PMID:
10230880
39.

Relationship between urea reduction ratio, demographic characteristics, and body weight for patients in the 1996 National ESRD Core Indicators Project.

Frankenfield DL, McClellan WM, Helgerson SD, Lowrie EG, Rocco MV, Owen WF Jr.

Am J Kidney Dis. 1999 Mar;33(3):584-91.

PMID:
10070924
40.

Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance.

Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang SM, Zhu X, Lazarus JM.

Am J Kidney Dis. 1999 Mar;33(3):523-34.

PMID:
10070917
41.
43.

Dose of hemodialysis and survival: differences by race and sex.

Owen WF Jr, Chertow GM, Lazarus JM, Lowrie EG.

JAMA. 1998 Nov 25;280(20):1764-8.

PMID:
9842952
44.
45.

Predicting hemodialysis access failure with color flow Doppler ultrasound.

Bay WH, Henry ML, Lazarus JM, Lew NL, Ling J, Lowrie EG.

Am J Nephrol. 1998;18(4):296-304.

PMID:
9653833
46.

Bioimpedance norms for the hemodialysis population.

Chertow GM, Lazarus JM, Lew NL, Ma L, Lowrie EG.

Kidney Int. 1997 Dec;52(6):1617-21.

47.

Anemia in hemodialysis patients: variables affecting this outcome predictor.

Madore F, Lowrie EG, Brugnara C, Lew NL, Lazarus JM, Bridges K, Owen WF.

J Am Soc Nephrol. 1997 Dec;8(12):1921-9.

48.

Development of a population-specific regression equation to estimate total body water in hemodialysis patients.

Chertow GM, Lazarus JM, Lew NL, Ma L, Lowrie EG.

Kidney Int. 1997 May;51(5):1578-82.

49.

Modeling mortality risk in hemodialysis patients using laboratory values as time-dependent covariates.

Culp K, Flanigan M, Lowrie EG, Lew N, Zimmerman B.

Am J Kidney Dis. 1996 Nov;28(5):741-6.

PMID:
9158214
50.

Supplemental Content

Loading ...
Support Center